abstract |
The present invention is directed, inter alia, to a method for promoting collateral circulation, including the step of exposing an individual to a therapeutically effective amount of an NO donor, wherein the therapeutically effective amount of the NO donor sufficiently promotes arteriogenesis to prevent collateral circulation in a patient physiological or pathological condition increase. |